Evidence map›Paper›PMID 39639331›Full record

ReviewJournal of orthopaedic surgery and research2024

Advancements in the treatment of osteochondral lesions of the talus.

Lianjie Cheng, Xuena Wang

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of orthopaedic surgery and research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07161128 (Pedobarographic Evaluation of Gait Biomechanics in Patients Treated With Arthroscopic Microfracture and Biologic Cartilage Scaffold for Osteochondral Defect), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07161128 naenrolling by invitationnot on this map

Pedobarographic Evaluation of Gait Biomechanics in Patients Treated With Arthroscopic Microfracture and Biologic Cartilage Scaffold for Osteochondral Defect (OCD) of Talus

TypeinterventionalSponsorGazi UniversityRan2024 to 2026Enrolled60ConditionsOsteochondral Defects of Talus, Gait Analysis, Microfracture Procedure, Biological ScaffoldArmsarthroscopic microfracture and biological scaffold implementation for osteochondral defects of talus
3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Additional cartilage treatment for small defects in chronic ankle instability shows no mid-term benefit and delays recovery: a randomized controlled trial.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Recombinant Human Amelogenin Protein Enhances Healing of Osteochondral Injury in a Goat Model.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lianjie ChengDepartment of Hand & Foot and Reconstructive Microsurgery, Shandong Provincial Hospital, Shandong First Medical University, Jinan, Shandong, China.
Xuena WangDepartment of Nephropathy and Rheumatology, Shandong Provincial Third Hospital, Shandong University, Jinan, 250031, Shandong, China. wangxuena85@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteochondral lesions of the talus (OLT) are common ankle joint pathologies, often caused by traumatic or non-traumatic factors. Due to the anatomical characteristics and limited blood supply of the talus, the spontaneous healing capacity of OLT is poor, posing challenges for clinical treatment. Traditional treatments include conservative therapy and surgical interventions, but their efficacy is limited. In recent years, significant advancements in OLT treatment have been achieved with developments in biomaterials science, cell biology, and tissue engineering. This article summarizes the latest research progress in various treatment methods, including conservative treatment, bone marrow stimulation, chondrocyte transplantation, and osteochondral grafting, and evaluates the role of biological augmentation agents such as platelet-rich plasma (PRP) and concentrated bone marrow aspirate (CBMA) in promoting cartilage repair. Additionally, the application of biological scaffold technology offers new prospects for cartilage regeneration. Although emerging therapies show potential in clinical practice, further research is needed to evaluate their long-term efficacy, indications, and safety. This article aims to provide valuable references for clinicians, researchers, and policymakers, promoting the development and refinement of OLT treatment strategies.

Indexed as

ChondrocytesTalusTissue EngineeringBone Marrow TransplantationCartilage, ArticularHumansPlatelet-Rich PlasmaTissue ScaffoldsBiological augmentation agentsBone marrow stimulationChondrocyte transplantationOsteochondral graftingOsteochondral lesions

Identifiers

PMID39639331
PMCPMC11622651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.